Abbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. MRVL
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. STZ

Go back to Abbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views

UBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call

February 1, 2016 8:33 AM EST

UBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following the company's 4Q earnings report. Street estimates suggested a lower 2016 outlook, driven by tougher FX in geographies where ABT has fewer natural hedges. However, the volume slowdown in oildriven economies like Venezuela took another dime or so out of the 2016 EPS... More

William Blair Downgrades Abbott Labs (ABT) to Market Perform

January 29, 2016 7:28 AM EST

William Blair downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.

Shares of Abbott Labs closed at $36.71 yesterday.

... More